Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Arthritis Care & Research|June 1, 2019
Large Variability of Frequency and Type of Physical Therapy in Patients in the German Network for Systemic SclerosisD Belz, P Moinzadeh, G Riemekasten, et al.
Scandinavian Journal of Rheumatology|July 25, 2018
Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) databaseP E Carreira, L Carmona, B E Joven, et al.
Annals of the Rheumatic Diseases|July 26, 2011
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centresJ Fransen, D Popa-Diaconu, R Hesselstrand, et al.
Annals of the Rheumatic Diseases|December 15, 2010
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesisP Dieudé, M Guedj, J Wipff, et al.
Zeitschrift Fur Rheumatologie|February 11, 2020
[Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]A Juche, E Siegert, U Mueller-Ladner, et al.
Arthritis and Rheumatism|September 8, 2011
Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotypeP Dieudé, M Bouaziz, M Guedj, et al.
Arthritis Research & Therapy|January 26, 2019
Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) surveyJ Blagojevic, S Bellando-Randone, G Abignano, et al.
Clinical Rheumatology|May 22, 2019
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher studyJelena Blagojevic, G Abignano, J Avouac, et al.
Annals of the Rheumatic Diseases|March 13, 2009
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosisY Allanore, C Meune, M C Vonk, et al.
Arthritis and Rheumatism|June 18, 2010
Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian populationJ Wipff, P Dieudé, M Guedj, et al.
Pageof 9